The Effect of Nurse Training on the Improvement of Subcutaneous Heparin Applications

NCT ID: NCT05469035

Last Updated: 2022-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-15

Study Completion Date

2022-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One of the most important duties and responsibilities of nurses is drug administration. During drug administration, the nurse uses appropriate administration techniques and ensures patient safety by knowing the drugs and their side effects. This study aimed to examine the effect of nurse training on the improvement of subcutaneous heparin applications. In this study, it was planned to train nurses by using two different training methods. These methods are online and face-to-face training.

In both methods, it was planned to evaluate the subcutaneous drug administration knowledge and skill of nurses before and after the training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Drug administration is a common nursing clinical intervention. The nurse ensures patient safety by using compatible administration techniques and being aware of the side effects of medications. Pharmacological agents such as heparins, vaccines, insulin, hormone drugs, etc., are generally inappropriate with oral, intravenous or intamuscular intake. Thereupon, they have to be administered by means of subcutaneous (SC) injection. Subcutaneous medications are injected into the tissue layer between the skin and the muscle that is called subcutaneous tissue where does not have a rich blood supply. Suitable areas for subcutaneous injction application are the lateral aspect of the upper arms, posterior aspect of the upper arms, anterior surface of the thigh, unders the scapulas and abdomen in the umbilical region. For the reason that abdominal region has an excess subcutaneous fat tissue, enough space for repeated injections and less muscle activity, it is highly preferred for subcutaneous injections. The angle of entry of the needle into the tissue depends on the needle length and the thickness of the subcutaneous tissue mass. A 90-degree angle is used if the subcutaneous tissue thicknes is about 5 cm. However, when it is 2.5 cm the angle of a 45-degree angle is recommended. To check whether the needle tip is in the vein or not during the application causes the needle movement in the tissue that then results in vascular damage, bleeding, ecchymosis and hematoma formation. Airlock technique in subcutaneous inections is recommended as it ensures that the entire drug is delivered to the tissue as well as preventing the escape of the drug.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nursing Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A randomized controlled, pre-post-test, mixed-method
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Nurses in the experimental group participated in mobile-based video learning.

Group Type EXPERIMENTAL

Mobile-based video

Intervention Type OTHER

Nurses in the experimental group participated in mobile-based video learning.

Control

Nurses in the experimental group participated in face-to-face learning.

Group Type ACTIVE_COMPARATOR

Face-to-face

Intervention Type OTHER

Nurses in the experimental group participated in face-to-face learning.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile-based video

Nurses in the experimental group participated in mobile-based video learning.

Intervention Type OTHER

Face-to-face

Nurses in the experimental group participated in face-to-face learning.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SC Heparin Interventions SC Heparin Interventions

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* volunteering to participate in the study

Exclusion Criteria

* not have administered subcutaneous heparin in the clinical practice
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Saglik Bilimleri University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Demet İnangil, PhD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Demet İnangil

Role: STUDY_CHAIR

Istanbul Sağlık Bilimleri University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Demet İnangil

Role: CONTACT

05303021160

References

Explore related publications, articles, or registry entries linked to this study.

Hegland PA, Aarlie H, Stromme H, Jamtvedt G. Simulation-based training for nurses: Systematic review and meta-analysis. Nurse Educ Today. 2017 Jul;54:6-20. doi: 10.1016/j.nedt.2017.04.004. Epub 2017 Apr 19.

Reference Type BACKGROUND
PMID: 28456053 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1640

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Parenteral Injection Training Module
NCT06761456 ACTIVE_NOT_RECRUITING NA